2C-O-22
Pharmaceutical compound
From Wikipedia, the free encyclopedia
2C-O-22, also known as 4-(2,2,2-trifluoroethoxy)-2,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and 2C families.[1][2][3] According to Daniel Trachsel, 2C-O-22 produced potential threshold effects at a dose of 42 mg plus 15 mg orally, with Trachsel listing its dose as 57 mg or more.[1][2] The drug's duration is unknown and its effects were not further described.[1][2] The receptor interactions of 2C-O-22 have been studied, with it having been found to act as a serotonin 5-HT2A receptor agonist among other actions.[3] 2C-O-22 was first described in the scientific literature by Trachsel in 2012.[2][1] It is a controlled substance in Canada under phenethylamine blanket-ban language.[4]
- None
| Clinical data | |
|---|---|
| Other names | 4-(2,2,2-Trifluoroethoxy)-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-4-(2,2,2-trifluoroethoxy)phenethylamine |
| Routes of administration | Oral[1][2] |
| Drug class | Serotonin receptor modulator; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C12H16F3NO3 |
| Molar mass | 279.259 g·mol−1 |
| 3D model (JSmol) | |
| |
| |